Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells.

In Vitro Cellular & Developmental Biology. Animal
Richard E SobelMarianne D Sadar

Abstract

Adenocarcinoma of the prostate comprises 95% of all prostate cancer. Commercially available primary cultures of "normal" prostate epithelial cells, PrECs, have been used as a convenient model to investigate neoplastic transformation. Here PrECs were characterized for the expression of lineage- and developmental-specific markers cytokeratin (CK) 8 and 18, p63, chromogranin A, TMEPAI, S100P, NKX 3.1, ANKH, and FN 1 as well as androgen receptor and prostate-specific antigen by Western blot and Northern blot analyses, immunohistochemistry, reverse transcriptase-polymerase chain reaction (RT-PCR), and quantitative real-time PCR. Immunohistochemical staining detected PrECs positive in varying degrees for p63, CK 8, and CK 18, with only the rare cell being positive for chromogranin A. The PrECs also tested positive for p63 protein by Western blot analysis. RT-PCR with PrEC cDNA showed products for FN 1 and S100P but not for ANKH and androgen receptor or prostate-specific antigen. This profile of markers in PrEC cells is consistent with that expected for pubertal prostate epithelial cells.

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Jan 1, 1989·Journal of Steroid Biochemistry·A O BrinkmannE Mulder
May 15, 1973·Biochemical and Biophysical Research Communications·D R Hewish, L A Burgoyne
Mar 20, 1968·Archives of Biochemistry and Biophysics·D S CoffeyH G Williams-Ashman
Nov 1, 1993·Histochemistry·J L KrijnenT H van der Kwast
Jan 1, 1993·Virchows Archiv. A, Pathological Anatomy and Histopathology·H Bonkhoff, K Remberger
Dec 13, 1996·The Journal of Biological Chemistry·C J BieberichG Jay
Dec 1, 1996·The Prostate·L AverboukhA B Pardee
Apr 16, 1998·The Prostate·J L PrescottD J Tindall
Jan 30, 1999·The Journal of Pathology·M E HarperR I Nicholson
Jul 1, 1996·Cancer Control : Journal of the Moffitt Cancer Center·S R Denmeade, J T Isaacs
Aug 24, 2001·Nature·S M DhanasekaranA M Chinnaiyan
Dec 26, 2001·The Journal of Biological Chemistry·Takeshi UedaMarianne D Sadar
Jan 5, 2002·Differentiation; Research in Biological Diversity·Y WangG Cunha
Aug 20, 2002·Genome Biology·Samuel E DePrimoJames D Brooks
Apr 15, 2003·The Prostate·Levi A GarrawayMassimo Loda
Nov 25, 2003·The American Journal of Pathology·Rolf I SkotheimFahri Saatcioglu
Oct 12, 2004·The International Journal of Biochemistry & Cell Biology·Annet HammacherElizabeth D Williams
Jan 12, 2005·The Journal of Urology·R E Sobel, M D Sadar
Jan 12, 2005·The Journal of Urology·R E Sobel, M D Sadar
Jan 22, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shannon Reagan-Shaw, Nihal Ahmad
Mar 25, 2005·Endocrine-related Cancer·D M Peehl

❮ Previous
Next ❯

Citations

Jan 26, 2013·The Journal of Clinical Investigation·Toshiaki YoshiokaFilippo G Giancotti
Oct 4, 2011·PloS One·Conrad David ValdezMark L Day
Oct 20, 2010·Free Radical Biology & Medicine·Weihua ShanTerry D Oberley
Jan 24, 2008·The Prostate·Kenneth J PientaRobert L Vessella
Oct 30, 2016·International Journal of Medical Microbiology : IJMM·Behnam SayanjaliHolger Brüggemann
Dec 10, 2015·Molecular Endocrinology·Meenakshi BhansaliLirim Shemshedini
Feb 16, 2012·Prostate Cancer and Prostatic Diseases·R S PriceL A deGraffenried
Feb 6, 2021·BMC Cancer·Kristen A MarcellusBernard J Jasmin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis